Powered by

Anavex Life Sciences Reports Fiscal Second Quarter 2018 Financial Results

May 10, 2018 - GlobeNewswire
Board and Executive Moves

Conference Call and Webcast Today at 4:30 p.m. ET

NEW YORK, May 10, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer's disease, Rett syndrome and other central nervous system (CNS) diseases, today reported financial results for the second fiscal quarter ended March 31, 20...